BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35021739)

  • 21. pH and redox dual stimulate-responsive nanocarriers based on hyaluronic acid coated mesoporous silica for targeted drug delivery.
    Lin JT; Du JK; Yang YQ; Li L; Zhang DW; Liang CL; Wang J; Mei J; Wang GH
    Mater Sci Eng C Mater Biol Appl; 2017 Dec; 81():478-484. PubMed ID: 28888000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Jun; 30(16):3009-19. PubMed ID: 19250665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folate-containing reduction-sensitive lipid-polymer hybrid nanoparticles for targeted delivery of doxorubicin.
    Wu B; Yu P; Cui C; Wu M; Zhang Y; Liu L; Wang CX; Zhuo RX; Huang SW
    Biomater Sci; 2015 Apr; 3(4):655-64. PubMed ID: 26222425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. pH-sensitive nanoparticles of poly(L-histidine)-poly(lactide-co-glycolide)-tocopheryl polyethylene glycol succinate for anti-tumor drug delivery.
    Li Z; Qiu L; Chen Q; Hao T; Qiao M; Zhao H; Zhang J; Hu H; Zhao X; Chen D; Mei L
    Acta Biomater; 2015 Jan; 11():137-50. PubMed ID: 25242647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coordinated pH/redox dual-sensitive and hepatoma-targeted multifunctional polymeric micelle system for stimuli-triggered doxorubicin release: Synthesis, characterization and in vitro evaluation.
    Wang L; Tian B; Zhang J; Li K; Liang Y; Sun Y; Ding Y; Han J
    Int J Pharm; 2016 Mar; 501(1-2):221-35. PubMed ID: 26851356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enzyme and Thermo Dual-stimuli Responsive DOX Carrier Based on PNIPAM Conjugated Mesoporous Silica.
    Ebrahimi SM; Karamat Iradmousa M; Rashed M; Fattahi Y; Hosseinzadeh Ardakani Y; Bahadorikhalili S; Bafkary R; Erfan M; Dinarvand R; Mahboubi A
    Iran J Pharm Res; 2022 Dec; 21(1):e130474. PubMed ID: 36915404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
    Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
    Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic nanocarriers of doxorubicin coated with poly(ethylene glycol) and folic acid: relation between coating structure, surface properties, colloidal stability, and cancer cell targeting.
    Kaaki K; Hervé-Aubert K; Chiper M; Shkilnyy A; Soucé M; Benoit R; Paillard A; Dubois P; Saboungi ML; Chourpa I
    Langmuir; 2012 Jan; 28(2):1496-505. PubMed ID: 22172203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging.
    Wang Y; Cui Y; Zhao Y; He B; Shi X; Di D; Zhang Q; Wang S
    Eur J Pharm Biopharm; 2017 Aug; 117():105-115. PubMed ID: 28363599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of surface functionalized hydroxyapatite nanoparticles for enhanced specificity towards tumor cells.
    Verma G; Shetake NG; Pandrekar S; Pandey BN; Hassan PA; Priyadarsini KI
    Eur J Pharm Sci; 2020 Mar; 144():105206. PubMed ID: 31870813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
    Kashyap S; Singh N; Surnar B; Jayakannan M
    Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo.
    Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN
    Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Folic acid-modified Prussian blue/polydopamine nanoparticles as an MRI agent for use in targeted chemo/photothermal therapy.
    Lin X; Cao Y; Li J; Zheng D; Lan S; Xue Y; Yu F; Wu M; Zhu X
    Biomater Sci; 2019 Jul; 7(7):2996-3006. PubMed ID: 31111139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biodegradable poly(D,L-lactide-co-glycolide)/poly(L-γ-glutamic acid) nanoparticles conjugated to folic acid for targeted delivery of doxorubicin.
    Jaimes-Aguirre L; Morales-Avila E; Ocampo-García BE; Medina LA; López-Téllez G; Gibbens-Bandala BV; Izquierdo-Sánchez V
    Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():743-751. PubMed ID: 28482586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and characterization of dual responsive mesoporous silica nanoparticles for breast cancer targeted therapy.
    Bhavsar DB; Patel V; Sawant KK
    Eur J Pharm Sci; 2020 Sep; 152():105428. PubMed ID: 32553643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PEGylated Poly(α-lipoic acid) Loaded with Doxorubicin as a pH and Reduction Dual Responsive Nanomedicine for Breast Cancer Therapy.
    Yang H; Shen W; Liu W; Chen L; Zhang P; Xiao C; Chen X
    Biomacromolecules; 2018 Nov; 19(11):4492-4503. PubMed ID: 30346147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A facile fabrication of upconversion luminescent and mesoporous core-shell structured β-NaYF
    Li C; Hou Z; Dai Y; Yang D; Cheng Z; Ma P; Lin J
    Biomater Sci; 2013 Feb; 1(2):213-223. PubMed ID: 32481801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. pH-Responsive Polymer-Stabilized ZIF-8 Nanocomposites for Fluorescence and Magnetic Resonance Dual-Modal Imaging-Guided Chemo-/Photodynamic Combinational Cancer Therapy.
    Qin YT; Peng H; He XW; Li WY; Zhang YK
    ACS Appl Mater Interfaces; 2019 Sep; 11(37):34268-34281. PubMed ID: 31454217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
    Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
    Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X; Zhao Y; Ng KW; Zhao Y
    Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.